IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Transformation of an alkylating regimen of thiotepa into tepa determines disease progression through GSTP1 gene polymorphism in metastatic breast cancer patients receiving thiotepa-containing salvage chemotherapy
Zhou, Xinna1; Wang, Xiaoli1; Song, Qingkun1; Yang, Huabing1; Zhu, Xishan1; Yu, Jing2; Song, Guohong2; Di, Lijun2; Ren, Jun1; Shao, Hong3; Lyerly, Herbert Kim4
关键词breast cancer glutathione S-transferase pi 1gene (GSTP1) single nucleotide polymorphism (SNP) thiotepa
刊名INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2015-11-01
DOI10.5414/CP202391
53期:11页:914-922
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pharmacology & Pharmacy
资助者Natural Science Foundation of China ; Suan G. Komen for Cure Foundation ; Youth Foundation of Beijing Shijitan Hospital ; Natural Science Foundation of China ; Suan G. Komen for Cure Foundation ; Youth Foundation of Beijing Shijitan Hospital
研究领域[WOS]Pharmacology & Pharmacy
关键词[WOS]DRUG-METABOLISM ; GLUTATHIONE ; PHARMACOGENOMICS ; ASSOCIATION ; EXPRESSION ; ONCOLOGY ; SURVIVAL ; THERAPY ; ENZYMES ; CYP2B6
英文摘要

Background: The shifts to second-line chemotherapy for metastatic breast cancer (MBC) were widely required based on pharmaceutical molecular profiles to reach out precision medicine. The emerging precise treatment of cancer requires the implementation of clarified pharmacogenetic profiles which are capable of elucidating the predictive responses to cancer chemotherapy. Therefore we were interested in the analysis of the roles of single nucleotide polymorphism (SNP) of GSTP1 (glutathione S-transferase pi 1 gene) alleles to identify pharmacological links with predictors of clinical responses and toxicities. Methods: 93 MBC patients receiving thiotepa plus docetaxel chemotherapy were enrolled in this study. Optimized CYP3A5, CYP2B6, and GSTP1 were predominantly selected as candidate genes and their three SNPs (CYP2B6 G516T, CYP3A5 A6986G, and GSTP1 A313G) were genotyped by matrix-assisted laser desorption ionization/time of flight (MALDI-TOF) mass spectrometry. Progression-free survival (PFS), disease control rate, and chemo-related toxicities were recorded. Results: GSTP1 A313G (rs1695) was identified to be related with disease progression. In particular, patients harboring AG/GG genotype demonstrated a statistically longer PFS than those with AA. Multivariate analysis confirmed that AG/GG genotype was associated with both clinical responses and liver-localized metastatic lesions. No correlation was found between these three SNPs and chemotherapy-induced toxicity. Conclusions: These results suggest that the GSTP1 polymorphism is a novel prognostic marker for clinical response to thiotepa-containing chemotherapy regimens. Such evidence could provide insight into the role of pharmacogenetics to deprive of biases in shifting regimens solely by empirical choices.

语种英语
所属项目编号81172534 ; SPCHIN1201 ; 2013-q-04
资助者Natural Science Foundation of China ; Suan G. Komen for Cure Foundation ; Youth Foundation of Beijing Shijitan Hospital ; Natural Science Foundation of China ; Suan G. Komen for Cure Foundation ; Youth Foundation of Beijing Shijitan Hospital
WOS记录号WOS:000365460200002
引用统计
被引频次:1[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/58296
专题北京大学临床肿瘤学院
作者单位1.Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
2.Capital Med Univ, Beijing Shijitan Hosp, Dept Med Oncol, Beijing Key Lab Therapeut Canc Vaccines,Canc Ctr, Beijing 100038, Peoples R China
3.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst,Dept Med Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China
4.Peking Univ, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing 100191, Peoples R China
推荐引用方式
GB/T 7714
Zhou, Xinna,Wang, Xiaoli,Song, Qingkun,et al. Transformation of an alkylating regimen of thiotepa into tepa determines disease progression through GSTP1 gene polymorphism in metastatic breast cancer patients receiving thiotepa-containing salvage chemotherapy[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS,2015,53(11):914-922.
APA Zhou, Xinna.,Wang, Xiaoli.,Song, Qingkun.,Yang, Huabing.,Zhu, Xishan.,...&Lyerly, Herbert Kim.(2015).Transformation of an alkylating regimen of thiotepa into tepa determines disease progression through GSTP1 gene polymorphism in metastatic breast cancer patients receiving thiotepa-containing salvage chemotherapy.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS,53(11),914-922.
MLA Zhou, Xinna,et al."Transformation of an alkylating regimen of thiotepa into tepa determines disease progression through GSTP1 gene polymorphism in metastatic breast cancer patients receiving thiotepa-containing salvage chemotherapy".INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 53.11(2015):914-922.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhou, Xinna]的文章
[Wang, Xiaoli]的文章
[Song, Qingkun]的文章
百度学术
百度学术中相似的文章
[Zhou, Xinna]的文章
[Wang, Xiaoli]的文章
[Song, Qingkun]的文章
必应学术
必应学术中相似的文章
[Zhou, Xinna]的文章
[Wang, Xiaoli]的文章
[Song, Qingkun]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。